Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add filters








Year range
1.
Acta Pharmaceutica Sinica ; (12): 2171-2176, 2022.
Article in Chinese | WPRIM | ID: wpr-936586

ABSTRACT

Piroxicam has polymorphism. Different crystalline forms can exhibit different physicochemical properties and biological activities. Analysis of the intermolecular interactions is essential to reveal the formation mechanism and differences of polymorphs. In this paper, Hirshfeld surface analysis and semi-empirical methods were used to calculate and analyze the intermolecular interactions in seven polymorphic forms of piroxicam. The results show that the Hirshfeld surface analysis method can clearly and intuitively reveal the intermolecular interactions, among which H…H, O…H/H…O and N…H/H…N interactions account for 95% of the total energy. There are differences in the proportion and distribution of the forces of different crystal forms. The energy calculation shows that the lattice energy of the hydrate is significantly lower than that of the anhydrous forms, and in the specific energy distribution, the contribution of the dispersion force is the most prominent. Further interaction energy analysis was found that within the distance of 3.8 Å from the center of the piroxicam molecule, different crystalline forms of piroxicam molecule have different interaction energies with surrounding molecules.

2.
Article | IMSEAR | ID: sea-194607

ABSTRACT

Background: Liver cirrhosis patients are highly susceptible to bacterial infections specially Spontaneous bacterial peritonitis (SBP) which is commonest infection. this study undertaken to understand liver function tests and Spontaneous bacterial peritonitis in patients of liver cirrhosis admitted to tertiary care hospital.Methods: A descriptive cross-sectional study conducted among Liver cirrhosis patients in tertiary care center. Total 100 liver cirrhotic patients were included in present study. All the patients were subjected for biochemical evaluation of Serum albumin and globulin level, Serum bilirubin, SGOT (Serum glutamic oxaloacetic transaminase), SGPT (Serum glutamic pyruvate transaminase) and Ascitic fluid polymorph nuclear neutrophil (PMN) count to diagnose SBP.Results: Spontaneous bacterial peritonitis was present in 12% patients. Relation of Serum bilirubin level and SBP was statistically significant. Relation of serum SGOT, SGPT level and serum globulin between SBP and non-SBP group was statistically non-significant.Conclusions: Liver cirrhosis patients are susceptible for bacterial infections because of defects in various host defense mechanism and hence patients of liver cirrhosis must be screened for spontaneous bacterial peritonitis along with liver function tests.

3.
Herald of Medicine ; (12): 1339-1343, 2017.
Article in Chinese | WPRIM | ID: wpr-667610

ABSTRACT

Objective To evaluate the polymorphism of levonorgestrel by kinds of analysis technologies, and get the preponderant pharmaceutical polymorph by in vitro assessment including the stability and solubility. Methods Three polymorphs were obtained by quick solvent removal and precipitation methods. These polymorphs were characterized by X-ray powder diffraction (PXRD), differential scanning calorimetry (DSC), infrared absorption spectroscopy (IR), Raman spectroscopy and microscope. Furthermore,the stability was studied by X-ray powder diffraction analysis technology and using the curve of solubility to evaluate the dissolution rate of the three crystal forms. Results The levonorgestrel polymorphs α,β and γ were identified. The results of stability indicated that the levonorgestrel polymorphs α and β were metastable while the levonorgestrel polymorph γ was stable,and the dissolution rate of α, β, γ decrease in turn. Conclusion The levonorgestrel polymorph α is preponderant pharmaceutical polymorph. And the research on preponderant pharmaceutical polymorph of levonorgestrel provides scientific basic data for its clinical drug evaluation and establishing the quality standards.

4.
Article in English | IMSEAR | ID: sea-180462

ABSTRACT

Mefenamic acid (MFA) and Nicotinamide (NIC) cocrystal formation in co-milling treatment was investigated by x-ray powder diffractometry (XRPD). Two polymorphic form of Mefenamic acid (MFA form I and MFA form II) were used to form a cocrystal with nicotinamide. Co-milling treatment was carried out at room temperature in a 1:2 molar ratio of MFA and NIC for various times up to 60 min. Samples were analyzed by XRPD. The XRPD showed that MFA form I and MFA form II formed cocrystal with NIC in the same diffractograms pattern. There was no intermediate amorphous form during milling process. The cocrystal formation mechanism was predicted via intermediate eutectic mixtures. The cocrystal formation from MFA form II (15 min) was faster than from MFA form I (45 min) which may explained by variations unit cell dimensions of MFA form I and MFA form II and also the polymorphic transformation of MFA form I.

5.
Herald of Medicine ; (12): 930-934, 2015.
Article in Chinese | WPRIM | ID: wpr-467293

ABSTRACT

Objective To establish a method for qualitative identification of polymorphs in pharmaceutical solid preparations of active pharmaceutical ingredients ( API ) . Methods We obtained the powder diffraction patterns of the polymorphic drug substance like nimodipine and roxithromycin in solid preparation material and completed quantitative identification for polymorphs by the quantitative detection and using PXRD technology, deduction calculation through the powder X-ray diffraction and comparing with standard diagram. Results Through the analysis of nimodipine and roxithromycin which came from 27 batches of solid preparations from 11 different manufacturers, and comparing to the standard patterns of pure polymorphs, the quantitative identification of different crystalline states of API in pharmaceutical preparations had been established. Conclusion The qualitative detection method for polymorphs of API in pharmaceutical preparations by powder X-ray diffraction has wide applicability and high accuracy, which can be used to identify the polymorphism of API in solid preparation,and also used to control the quality of solid preparations commonly as a qualitative analysis method.

6.
Journal of China Pharmaceutical University ; (6): 575-578, 2015.
Article in Chinese | WPRIM | ID: wpr-481932

ABSTRACT

The aim of this study was to establish the methods to identify crystal form of dasatinib in tablets.X-ray powder diffraction(XRPD)and solid-state nuclear magnetic resonance(ssNMR)were used to analyze the crystal form of dasatinib in Sprycel? tablets and Yinishu? tablets.The results showed that monohydrate and anhydrate were identified in Sprycel? and Yinishu? tablets respectively;with no detectable anhydrate in Sprycel? tablets and no detectable monohydrate in Yinishu? tablets.The results of XRPD and ssNMR were consistent;and could be both applied in the crystal form identification of dasatinib in tablets.

7.
Cuad. méd.-soc. (Santiago de Chile) ; 47(3): 191-199, sept. 2007. ilus, tab
Article in Spanish | LILACS | ID: lil-589270

ABSTRACT

Se explica lo que es un sólido cristalino y el polimorfismo en general. Se muestra la relación estructura cristalina/propiedades físicas y químicas a partir del átomo de carbono. Se entrega la definición de polimorfismo de la FDA. Se muestra el polimorfismo del paracetamol y se dan algunas cifras relativas a la existencia del polimorfismo en principios activos de medicamentos. Se explica que la consecuencia más importante para los polimorfos farmacéuticos es la diferencia de solubilidad y cómo eso afecta propiedades como la biodisponibilidad y la bioequivalencia, entre otras. Se muestra la dificultad de elaboración de formas farmacéuticas a partir de polimorfos específicos a través del caso emblemático del medicamento Ritonavir. Se muestran las consecuencias económicas y de salud pública en América Latina a partir de una experiencia en países vecinos como Brasil y Argentina y se informa de una Resolución del ISP en Chile que reconoce la existencia de los polimorfos y su importancia en la estabilidad y Bio-Disponibilidad de los productos farmacéuticos.


An explanation is given of crystalline solids and polymorphism in general. The crystal structure/chemical and physical properties relation is illustrated for the element carbon. The FDA's definition of polymorphism is given. The polymorphism of phenacetin (para-acetylaminophenol) is shown and some figures are given for the existence of polymorphism in medicinal active principles. The fact that solubility difference is the most important consequence of pharmaceutical polymorphs is stated, and how it affects properties like bioavailability and bioactivity, among others, is explained. The difficulty of making pharmaceutical preparations from specific polymorphs is illustrated by means of the emblematic case of the drug Ritonavir. The economic and public health consequences in Latin America are shown using the experience of neighboring countries like Brazil and Argentina, and a Resolution of the Public Health Institute (ISP) of Chile in relation to the polymorphism is reported.


Subject(s)
Humans , Chemistry, Pharmaceutical , Crystallization , Acetaminophen/chemistry , Ritonavir/chemistry
8.
Chinese Journal of Immunology ; (12)2000.
Article in Chinese | WPRIM | ID: wpr-546904

ABSTRACT

Objective:To investigate the HLA-DRB1 allele polymorphism of the Tu race population in Qinghai region of China.Methods:Polymerase chain reaction and hybridizations of sequence-specific olignucleotide probe was used to detect HLA-DRB1 alleles in 50 unrelated healthy Tu individuals from Qinghai region,and the results were compared with those of minority populations in China.Results:Sixteen of alleles were detected and identified for HLA-DRB.HLA-DRB11*04,DRB1*08,DRB1*14,DRB1*15,DRB3*,DRB4* were the most common alleles.The frequency of DRB1*06,DRB1*07,DRB1*09,DRB1*13,DRB1*16,DRB1*23 were lower.Conclusion:The allelic polymorphism of HLA loci of Tu race population in Qinghai area has its own characteristics.

SELECTION OF CITATIONS
SEARCH DETAIL